B BIOTICARE Trademark

Trademark Overview


On Friday, July 19, 2024, a trademark application was filed for B BIOTICARE with the United States Patent and Trademark Office. The USPTO has given the B BIOTICARE trademark a serial number of 98657956. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, November 12, 2025. This trademark is owned by Caelus Pharmaceuticals B.V.. The B BIOTICARE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical and healthcare information in the field of diabetes management, hyperglycemia, cardiovascular health, weight management, metabolic health, and gut health; medical consultation and medical services, namely, telemedicine and remote healthcare by health care professionals via telecommunication networks; Health counselling, health screening services, internet-based health care information services, and medical dietic counseling for the treatment and management of diabetes and metabolic conditions; preparation of reports relating to medical matters, and providing medical diagnostic information to patients and medical practitioners relating to medical information and patient treatment plans; medical testing and analysis for diagnostic purposes; provision of information relating to pharmaceuticals, dietary supplements, and food supplements for diabetes management.

Pharmaceutical products for the prevention and treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions; dietetic foodstuffs and dietetic substances, namely, probiotic supplements, dietary supplements, dietary fibers, functional foods, dietetic foods, dietetic beverages, and nutritional bars adapted for medical use; food supplements and nutritional supplements for human beings; medicinal healthcare preparations for the treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions.
b bioticare

General Information


Serial Number98657956
Word MarkB BIOTICARE
Filing DateFriday, July 19, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, November 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkBIOTICARE BIOTIC CARE
Indication of Colors claimedThe color(s) orange, fuchsia, purple, white, and black is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized black letters "BIOTICARE" below a stylized white letter "B" surrounded by a circle-like design with orange, fuchsia, and purple dots.
Goods and ServicesProviding medical and healthcare information in the field of diabetes management, hyperglycemia, cardiovascular health, weight management, metabolic health, and gut health; medical consultation and medical services, namely, telemedicine and remote healthcare by health care professionals via telecommunication networks; Health counselling, health screening services, internet-based health care information services, and medical dietic counseling for the treatment and management of diabetes and metabolic conditions; preparation of reports relating to medical matters, and providing medical diagnostic information to patients and medical practitioners relating to medical information and patient treatment plans; medical testing and analysis for diagnostic purposes; provision of information relating to pharmaceuticals, dietary supplements, and food supplements for diabetes management.
Goods and ServicesPharmaceutical products for the prevention and treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions; dietetic foodstuffs and dietetic substances, namely, probiotic supplements, dietary supplements, dietary fibers, functional foods, dietetic foods, dietetic beverages, and nutritional bars adapted for medical use; food supplements and nutritional supplements for human beings; medicinal healthcare preparations for the treatment of diabetes, hyperglycemia, hypoglycemia, insulin resistance, cardiovascular diseases, weight management, metabolic syndrome, metabolic imbalances, gastrointestinal disorders, and related endocrine and metabolic health conditions.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 19, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCaelus Pharmaceuticals B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZegveld 3474KG
NL

Trademark Events


Event DateEvent Description
Friday, July 19, 2024NEW APPLICATION ENTERED
Wednesday, February 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 12, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 13, 2025ASSIGNED TO EXAMINER
Saturday, February 15, 2025NON-FINAL ACTION WRITTEN
Saturday, February 15, 2025NON-FINAL ACTION E-MAILED
Saturday, February 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 15, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, May 15, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, August 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 12, 2025FINAL REFUSAL WRITTEN
Wednesday, November 12, 2025FINAL REFUSAL E-MAILED
Wednesday, November 12, 2025NOTIFICATION OF FINAL REFUSAL EMAILED